FN2 Research
Markets, explained.
Cited, no-noise breakdowns of why stocks move — earnings reactions, macro shifts, and the data behind the headlines.
Two-Front Supply Shock: Hormuz Blockade Bites as Black Sea Grain Corrupts
Brent is holding above $87 with the US declaring its Iran blockade "indefinite," while wheat futures jumped 3% after Ukraine knocked out two major Russian grain terminals. Energy and defense stocks are bid; equities are slipping. The question is whether these two supply disruptions converge into a single inflationary shock.
Energy Leads, Tech Cools: A Market Split Between Hormuz and Rate Relief
The S&P 500 steadies near records as oil surges on Strait of Hormuz escalation, semis take profit despite blowout earnings, and July's mild CPI takes a September rate hike off the table.
SpaceX Lockup Test Passed, But the Equity Supply Flood Is Just Beginning
SpaceX's first lockup expiry defied fears with a 35% surge, but the real test of equity supply-demand arrives Aug 20 and beyond — with biotech IPOs, PE secondaries, and Goldman's $1.3T buyback vs. $1.1T issuance framework setting the terms.
Hormuz at a Trickle, Russian Oil in the Crosshairs: Markets Bet on Calm the Tankers Contradict
Brent crude is up ~5% this week to ~$87 as Hormuz tanker traffic runs 90% below pre-war levels and the Senate's 100% tariff bill on Russian oil buyers heads to the House. The VIX sits at 15. The market is betting on calm the tankers contradict.
AI Earnings and Cooling CPI Push Stocks to Records — Oil Tests the Foundation
The Nasdaq's 1.2% rally is the cleanest read on the August tape: AI-infrastructure earnings are doing the heavy lifting, and soft July CPI cleared the Fed runway. But Brent crude at $88 on an indefinite Iran blockade is the risk the VIX is not pricing.
SpaceX Lockup Test Meets Biotech IPO Surge: A Market-Structure Checkpoint
SpaceX's first lockup tranche freed 911 million shares — more than its IPO float — and the stock rose. Biotechs raised $1.2B the same week. But the staggered unlock schedule means the real tests arrive Aug 20, September, and October.
Three Chokepoints, One Supply Chain Shock: Why Shipping Stocks Are the Real Hormuz Signal
Three simultaneous shipping chokepoint crises — Hormuz, Bab el-Mandeb, and the Black Sea — are colliding with US-China trade escalation and a new Senate-passed Russian energy sanctions bill. Shipping stocks are the real signal.
Nasdaq Leads S&P 500 to Record as AI Infrastructure Demand Overwhelms Flat Inflation
The S&P 500 closed at a record 7,798.99 on August 13 as the Nasdaq 100 led with a 1.16% gain while the Dow industrials added just 0.14%. CoreWeave's sold-out capacity and $104B backlog, Meta's compute-monetization pivot, and Tesla's autonomy re-rating are driving a narrow AI-infrastructure-led rally against a backdrop of tame 3.46% CPI that keeps the Fed on hold.
IPO Market at an Inflection: Summer Lull Masks Structural Shift
SpaceX's $100B lockup held, the SEC proposed rescinding Reg NMS Rule 611, and private secondaries hit $121B in H1 — the autumn IPO pipeline will arrive into a rewired market.
Two Chokepoints, One Sanctions Bill: The Risk the Record-High Market Isn't Pricing
The S&P 500 hit a record close of 7,798.86 on cooling inflation, with gold and oil both selling off — even as the Strait of Hormuz remains blocked, the Senate's Graham sanctions bill threatens third-country Russian oil buyers, and Ukraine's strike on Novorossiysk disrupted Russia's grain exports. The market is betting diplomacy outpaces depletion. The margin is narrowing.